Identification of neoplasms expressing programmed cell death 1-ligand 1 (clone SP263)
Identification of neoplasms expressing programmed cell death 1-ligand 1(clone 28-8)
CITRA - Overview: Citrate Excretion, Random, Urine
Diagnosing risk factors for patients with calcium kidney stones using random urine specimens Monitoring results of therapy in patients with calcium stones or renal tubular acidosis
BUPS - Overview: Buprenorphine Screen, Random, Urine
Screening for drug abuse or use of buprenorphine
MPHNU - Overview: Methylphenidate and Metabolite, Random, Urine
Monitoring urine methylphenidate and ritalinic acid concentrations to assess compliance in patients
PNPAB - Overview: Paraneoplastic Pemphigus Antibody, IgG, Serum
Diagnosis of paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome in the setting of erosive or lichenoid mucocutaneous disease
BRIVA - Overview: Brivaracetam, Plasma
Assessing compliance and toxicity for brivaracetam
DULOX - Overview: Duloxetine, Serum
Monitoring duloxetine serum concentration during therapy Evaluating potential duloxetine toxicity Evaluating patient compliance
GQ1ES - Overview: Ganglioside GQ1b Antibody, IgG, ELISA, Serum
Evaluating patients with an underlying demyelinating neuropathy Supporting the diagnosis of a ganglioside GQ1b IgG-related disorder
POSA - Overview: Posaconazole, Serum
Monitoring posaconazole therapy